TSE:TRI

Thomson Reuters Corp (TRI.TO)

147.65
+4.80 (3.36%)
as of Aug 13, 2026, 8:00:00 pm Market Open.
221 watching
0
Investor Insights
star iconAug 13, 2026, 12:00 am

This summary was created by AI, based on 37 opinions in the last 12 months.

Thomson Reuters Corp (TRI-T) is experiencing a mix of skepticism and optimism driven by fears surrounding AI's potential impact on its services, particularly in the legal and accounting sectors. Despite these concerns, many analysts believe TRI’s proprietary data and established market position provide some insulation against AI disruption. The company recently reported solid earnings growth and is investing in share buybacks, indicating confidence in its future. Several experts view the current valuation as more attractive than before and see opportunities for long-term growth, while caution still exists due to valuation discussions and market sentiment. The firm's traditional business model continues to be seen as viable, and many believe it's well-positioned to integrate AI into its offerings, potentially enhancing its competitive advantage.

consensus icon
Consensus
Buy
valuation icon
Valuation
Undervalued
review icon
Similar
TMX,TMX
PAST TOP PICK
(A past top pick Feb 20/04. No change.) Still likes and feels it is undervalued. 70% of its revenue is the US which has hurt.
DON'T BUY
An exceedingly well run company. Great products. No growth and the stock is expensive.
DON'T BUY
They have a lot of competition in their sector right now which is why the stock has been stuck where it is. Well-run and good assets but think it's overvalued.
BUY
With the stock market going up, this company is attractive.
TOP PICK
Earnings where a little disappointing. Feels they are getting back on track, producing a lot of cash. Sales are a quite strongly. Could have a dividend increase.
DON'T BUY
Their products are not having a particularly good time, and in fact are declining. Have not been able to rally through the stock market rally. A classic under performer and if the market should weaken it will drop more so.
BUY
They do their job very well. 12/15% earnings growth. A very solid, steady stock.
TOP PICK
Was hit hard last year by the strong Cdn$. Has also had slower growth. Last week they had an earnings warning. This has brought it down to a good price. A cash flow rich business.
BUY
Loves this company. Likes their strategy. Expect them to grow 6/7 percent per year.
HOLD
Continuing to hit its quarterly earnings targets.
DON'T BUY
Model price is $32, dead money. Wouldnt touch it, above model price.
TOP PICK
It has got some pretty decent growth and earnings coming through. Good repeat business coming through from the scientific and legal side.
DON'T BUY
The trouble with this company is that they report in US$. Good business and globally diversified but very sensitive to changes in currency.
BUY
Well positioned. Could benefit from a period of market consolidation. It also looks attractive on a technical basis. Safe money.
BUY
We are at the bottom of the economical cycle so expects things will pick up.
Showing 556 to 570 of 718 entries